₹1,890.00 4.70 (0.25%)
04:01 PM, 10-Feb-2026₹1,885.50 0.70 (0.04%)
03:47 PM, 10-Feb-2026BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
Last Updated: 10-Feb-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 31,147 |
Traded Value (₹ Cr) | 0.55 |
Volume (Shares) | 2,915 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,130.00 |
52-Week High Date | 29-Jul-2025 |
52-Week Low (₹) | 1,200.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 31,073 |
| EPS - TTM (₹) [C] | 51.42 |
| P/E Ratio (X) [C] | 36.67 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 1,800.00 |
| Latest Dividend Date | 14-Aug-2025 |
| Dividend Yield (%) | 0.96 |
| Book Value Share (₹) [C] | 580.41 |
| P/B Ratio (₹) [C] | 3.25 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| HDFC Mid Cap Fund - Regular (G) | 1128.60 | 61,11,753 | 1.22 |
| HDFC Mid Cap Fund - Regular (IDCW) | 1128.60 | 61,11,753 | 1.22 |
| HDFC Mid Cap Fund - Direct (IDCW) | 1128.60 | 61,11,753 | 1.22 |
| HDFC Mid Cap Fund - Direct (G) | 1128.60 | 61,11,753 | 1.22 |
| SBI Large & Midcap Fund (IDCW) | 585.37 | 31,70,000 | 1.56 |
| SBI Large & Midcap Fund (G) | 585.37 | 31,70,000 | 1.56 |
| SBI Large & Midcap Fund - Direct (G) | 585.37 | 31,70,000 | 1.56 |
| SBI Large & Midcap Fund - Direct (IDCW) | 585.37 | 31,70,000 | 1.56 |
| ICICI Pru India Opportunities Fund (G) | 556.32 | 30,12,666 | 1.58 |
| ICICI Pru India Opportunities Fund (IDCW) | 556.32 | 30,12,666 | 1.58 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| 25-Sep-2025 | Motilal Oswal | Buy | 2,340 | |
| 04-Feb-2025 | Elara Capital | Buy | 1,841 | |
| 06-Nov-2024 | Motilal Oswal | Buy | 1,970 |
| Today's Low/High (₹) | 1,862.80 1,896.80 |
| Week Low/High (₹) | 1,812.70 1,985.00 |
| Month Low/High (₹) | 1,650.00 1,985.00 |
| Year Low/High (₹) | 1,277.80 2,131.00 |
| All time Low/High (₹) | 861.50 4,350.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -0.46% | -0.54% | 0.64% | 0.81% |
| 1 Month | 12.18% | 12.19% | 0.83% | 0.98% |
| 3 Month | 0.21% | 0.23% | 0.88% | 1.41% |
| 6 Month | -2.46% | -2.54% | 5.53% | 6.45% |
| 1 Year | 27.47% | 27.58% | 9.01% | 10.92% |
| 3 Year | 43.64% | 43.46% | 38.88% | 45.24% |
Chairman / Executive Director / MD / CEO : SRINIVAS SADU
Independent Non Exe. Director : UDO JAHANNES VETTER
Independent Non Exe. Director : Satyanarayana Murthy Chavali
Independent Non Exe. Director : ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Independent Non Exe. Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Wenjie Zhang
Non-Exec & Non-Independent Dir : Wei Huang
CS / Compliance Officer / Vice President : SAMPATH KUMAR PALLERLAMUDI
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,890.00 at 04:01 PM IST on 10th Feb 2026. Gland Pharma Ltd share price was up by 0.25% over the previous closing price of Rs 1,885.30. Gland Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 31,147 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,130.00 and 52-week low share price is Rs 1,200.00.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 261.48 crore on a total income of Rs 1,758.54 crore for the quarter ended 2025.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Anthem Bioscienc, Ipca Labs., Ajanta Pharma, Gland Pharma, J B Chemicals &, Emcure Pharma, Wockhardt.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows: